Therefore, we used chemogenetic strategies to selectively activate or inhibit D1R- or D2R-containing neurons in the SNpc or dSTR, which also provided guidance on the clinical treatment of TS, such as deep brain stimulation (DBS). The gene discussed is DRD1; the disease is Timothy syndrome.